Compare Tempo Scan Pacific Tbk. (TSPC) vs Reksa Dana Indeks Cipta ETF Index LQ45 (XCLQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempo Scan Pacific Tbk. vs Reksa Dana Indeks Cipta ETF Index LQ45 — how do they compare? Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume), while Reksa Dana Indeks Cipta ETF Index LQ45 trades at Rp67 (market cap 8.12B, 27K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 1438.4× Reksa Dana Indeks Cipta ETF Index LQ45's market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 27K). Which is the better fit depends on your goals.
| TSPC | XCLQ | |
|---|---|---|
Market Cap | 11.68T | 8.12B |
Volume | 429.7K | 27K |
Lot | 4.3K | 270 |
Turnover | 1.11B | 2.03M |
Average Price | 2,591.65 | 75.04 |
Value | 1.11B | 2.03M |
Indicative Equilibrium Price | 2,580 | — |
Indicative Equilibrium Volume | 100 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
